FOXA3 | Forkhead box A3 | Transcription factors
| | | | | Group enriched |
GOLT1A | Golgi transport 1A | Predicted membrane proteins
| | | | | Group enriched |
GPA33 | Glycoprotein A33 (transmembrane) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
IGSF23 | Immunoglobulin superfamily, member 23 | Predicted membrane proteins
| | | | | Group enriched |
MYO1A | Myosin IA | Disease related genes Plasma proteins
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SULT1E1 | Sulfotransferase family 1E, estrogen-preferring, member 1 | Cancer-related genes Enzymes
| | | | | Group enriched |
AC106876.2 | Uncharacterized protein | | | | | | Group enriched |
ARL14 | ADP-ribosylation factor-like 14 | | | | | | Group enriched |
ASAH2 | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Group enriched |
CLCA1 | Chloride channel accessory 1 | Predicted secreted proteins
| | | | | Group enriched |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
EPS8L3 | EPS8-like 3 | | | | | | Group enriched |
GDPD2 | Glycerophosphodiester phosphodiesterase domain containing 2 | Cytoskeleton related proteins Enzymes Predicted membrane proteins
| | | | | Group enriched |
ITLN1 | Intelectin 1 (galactofuranose binding) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | | | | Group enriched |
KCNK16 | Potassium channel, subfamily K, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
LCN15 | Lipocalin 15 | Predicted secreted proteins
| | | | | Group enriched |
MAB21L2 | Mab-21-like 2 (C. elegans) | | | | | | Group enriched |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
MUC3A | Mucin 3A, cell surface associated | Predicted membrane proteins
| | | | | Group enriched |
REG1A | Regenerating islet-derived 1 alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC35G1 | Solute carrier family 35, member G1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A9 | Solute carrier family 5 (sodium/sugar cotransporter), member 9 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC7A9 | Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
AL162431.1 | Uncharacterized protein | | | | | | Group enriched |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | | | | Group enriched |
C11orf86 | Chromosome 11 open reading frame 86 | | | | | | Group enriched |
CDHR2 | Cadherin-related family member 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CLRN1 | Clarin 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
DGAT1 | Diacylglycerol O-acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ERN2 | Endoplasmic reticulum to nucleus signaling 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GPR112 | G protein-coupled receptor 112 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
IHH | Indian hedgehog | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRT20 | Keratin 20 | Plasma proteins
| | | | | Group enriched |
MLN | Motilin | Predicted secreted proteins
| | | | | Tissue enriched |
MS4A18 | Membrane-spanning 4-domains, subfamily A, member 18 | Predicted membrane proteins
| | | | | Tissue enriched |
MT1B | Metallothionein 1B | | | | | | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MUC2 | Mucin 2, oligomeric mucus/gel-forming | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NOS2 | Nitric oxide synthase 2, inducible | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |